Position in PRME
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,621,125
+$1,613,152 QoQ
Shares Held
981,335
+70.1% QoQ
Ownership
0.541%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 186 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. PRME ranks #159 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in PRME
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,621,125 | 981,335 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,007,973 | 577,004 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,248,599 | 648,012 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $614,064 | 110,842 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $356,941 | 144,511 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $224,721 | 112,926 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,257,388 | 430,613 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,877,431 | 485,125 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,196,812 | 427,396 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,949,940 | 421,420 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,169,479 | 470,596 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,887,203 | 302,642 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,161,093 | 147,515 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,848,282 | 150,267 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $879,928 | 47,359 | Shares | Defined | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||